American International Group, Inc. Avidity Biosciences, Inc. Transaction History

American International Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$9.16 - $25.52 $2,857 - $7,962	-312 Reduced 0.85%	36,455 $930,000
Q4 2023 Feb 13, 2024	BUY	$4.87 - $9.37 $7,241 - $13,933	1,487 Added 4.21%	36,767 $332,000
Q3 2023 Nov 13, 2023	BUY	$6.3 - $11.35 $7,900 - $14,232	1,254 Added 3.69%	35,280 $225,000
Q2 2023 Aug 04, 2023	BUY	$10.62 - $17.34 $26,762 - $43,696	2,520 Added 8.0%	34,026 $377,000
Q1 2023 May 12, 2023	BUY	$15.35 - $25.65 $95,108 - $158,927	6,196 Added 24.48%	31,506 $483,000
Q4 2022 Feb 10, 2023	BUY	$10.06 - $22.66 $10,029 - $22,592	997 Added 4.1%	25,310 $561,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $22,107 - $33,504	1,430 Added 6.25%	24,313 $397,000
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $46,799 - $85,813	4,186 Added 22.39%	22,883 $332,000
Q1 2022 May 13, 2022	SELL	$14.2 - $23.78 $18,687 - $31,294	-1,316 Reduced 6.58%	18,697 $345,000
Q4 2021 Feb 11, 2022	SELL	$20.4 - $28.66 $12,219 - $17,167	-599 Reduced 2.91%	20,013 $476,000
Q3 2021 Nov 12, 2021	BUY	$18.16 - $25.21 $66,320 - $92,066	3,652 Added 21.53%	20,612 $508,000
Q2 2021 Aug 13, 2021	SELL	$19.62 - $29.26 $15,872 - $23,671	-809 Reduced 4.55%	16,960 $419,000
Q1 2021 May 07, 2021	BUY	$20.28 - $28.15 $163,193 - $226,523	8,047 Added 82.77%	17,769 $388,000
Q4 2020 Feb 12, 2021	SELL	$24.73 - $35.12 $6,899 - $9,798	-279 Reduced 2.79%	9,722 $248,000
Q3 2020 Nov 04, 2020	BUY	$23.35 - $35.94 $233,523 - $359,435	10,001 New	10,001 $282,000

255

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.2B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.